HIGH-PERFORMANCE TEST HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD Russian patent published in 2019 - IPC G01N30/88 G01N33/15 

Abstract RU 2691136 C2

FIELD: medicine.

SUBSTANCE: invention relates to a method for high-performance test (HTT) high-performance liquid chromatography for testing samples of pharmaceutical compositions. Method of carrying out HPLC with high throughput comprises: lowering containers with pre-weighed samples into plastic flasks; adding the solution to each set from the container and the flasks through the dispensing nozzle of the flasks; agitation of each set of a plastic flask, a container and a solution until dissolving the sample; centrifuging each set of plastic flask, container and solution; loading an aliquot of the supernatant obtained at the centrifugation step into an HPLC column; and starting column with movable phase.

EFFECT: possibility of measuring a large volume of samples and high accuracy.

16 cl, 15 dwg, 3 tbl

Similar patents RU2691136C2

Title Year Author Number
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 2015
  • Phenix, Brian, Dean
  • Bagnol, Laurent, Jean-Claude
  • Brodeur, Geoffrey, Glen
  • Chandran, Sachin
  • Dokou, Eleni
  • Ferris, Lori, Ann
  • Knezic, Dragutin
  • Mccarty, Katie, Lynn
  • Medek, Ales
  • Waggener, Sara, A.
RU2744460C2
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY A TRANSMEMBRANE REGULATOR OF CYSTIC FIBROSIS (CFTR) 2013
  • Vervejs Marinus Yakobus
  • Karkare Radkhika
  • Mur Majkl Duglas
RU2692676C2
METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING CFTR MEDIATED DISEASES 2014
  • Swinney, Kelly, Ann
  • Hurter, Patricia, Nell
  • Nadig, David, E.
  • Smith, David
  • Thomas, Vance, Hayden
  • Warman, Martin, Paul
RU2718044C2
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBRIOSIS 2019
  • Chu, Cathy
  • Dhamankar, Varsha
  • Dokou, Eleni
  • Haseltine, Eric L.
  • Moskowitz, Samuel
  • Robertson, Sarah
  • Waltz, David
  • Chen, Weichao George
RU2822220C2
NEW TREATMENT 2015
  • Ebbott-Banner Ketarin
  • Khanrakhan Dzhon
  • Tomas Devid
RU2688191C2
SOLID FORMS OF N-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL-)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUIINOLINE-3-CARBOXAMIDE 2009
  • Chzhan Behjli
  • Kravets Mariush
  • Botfild Martin
  • Grotenkhejs Peter D J.
  • Van Gur Fredrik
RU2518479C2
METHOD FOR IDENTIFYING MUCOVISCIDOSIS CAUSING MUTATIONS IN CFTR HUMAN GENE, KIT OF PRIMERS, BIOCHIP, KIT OF TARGETS AND TEST SYSTEMS USED IN METHOD 2012
  • Vorob'Ev Evgenij Vladimirovich
RU2529717C2
METHOD FOR OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 2010
  • Ambkhaikar Narendra Bkhalchandra
  • Kh'Juz Robert
  • Kharli Dennis Dzhejms
  • Li Ehlejn Chungmin
  • Littler Bendzhamin
  • Numa Mekhdi
  • Reper Shtefani
  • Shet Urvi
RU2553989C2
FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZONIC ACID 2013
  • Vervejis Marinus Yakobus
RU2644723C2
INJECTION OF DEUTERATED CFTR AMPLIFIERS 2016
  • Braman, Virginia
RU2761344C2

RU 2 691 136 C2

Authors

Rasmussen, Henrik, Torstholm

Borsje, Eric

Dates

2019-06-11Published

2015-11-18Filed